We Advocate for and Support the Development of Biotechnologies Focused on Ending Age-Related Diseases
News
Human Safety Trial of NMN Concludes
A human trial of NMN has recently concluded, and the results are not impressive at all; however, this is perfect...Posted in: News
More News
New Potential Treatment for Atherosclerosis Identified
A team of researchers from the University of Sheffield in the UK has identified a protein that plays a key role ...Posted in: News
Even More News
Excluding Oct4 from OSKM Yields Positive Results
A recent open-access study published in Cell Stem Cell has shown that excluding Oct4 from the OSKM cocktail redu...Posted in: News
Popularizing Science Through Public Engagement
LifeXtenShow
LifeXtenShow – Genomic Instability
Today on LifeXtenShow, Giuliano discusses genomic instability, one of the primary hallmarks of aging – and...Posted in: LifeXtenShow, News
Webinars
SENS MitoMouse Q&A Webinar Video
On Friday, October 25, we hosted a Q&A webinar with the team behind MitoMouse, the second MitoSENS program t...
Journal Club
Journal Club November 2019 – Combination Gene Therapy Tre...
For the November episode of the Journal Club, Dr. Oliver Medvedik will be reviewing a new study from a team of r...Posted in: Journal club